ArticleScientific reports2025
AUPA: weakly supervised approach for streamlining breast cancer diagnostic workflow by WSI histological type classification for efficient IHC triage.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In routine breast cancer diagnostics, pathologists often review each case twice-first to determine the need for immunohistochemical (IHC) stains, and a second time to issue the final diagnosis-creating significant workload and delays. We present an artificial intelligence-based system designed to streamline this process by distinguishing invasive carcinoma from fibroadenoma and in situ lesions in Whole Slide Images of H&E-stained breast biopsies, enabling automatic IHC stain requests for these lesions, while abstaining on non-target or low-confidence cases. The system leverages a weakly supervised method, trained directly on final diagnostic labels without the need for manual annotations. It achieves over 91% sensitivity and specificity across histological types in internal validation and shows strong generalizability in two external pilot studies. In a real-world setting, the system could determine if IHC stains should be ordered (sensitivity and specificity > 96%) and which stains (sensitivity and specificity > 81%). Compared to both expert pathologists and state-of-the-art models, our model performs competitively. Designed for real-world deployment, it is fully integrated into the Digital Imaging and Communications in Medicine (DICOM) standard. In validation data, it could have saved up to 43 h of pathologists' time. Our model represents a scalable solution for more efficient diagnostic BC workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.